Karachi: Highnoon Laboratories Limited has announced a change in its leadership as Mr. Tausif Ahmad Khan, the former Chairman, has stepped down from his position effective July 1, 2025. The company has appointed Mr. Tariq Wajid, an Independent Director, as the new Chairman beginning the same date.

Mr. Tariq Wajid's appointment aligns with the company's ongoing efforts to bolster its governance structure and strategic direction. Highnoon Laboratories Limited, a key player in the pharmaceutical industry, has made this leadership change public in a notification intended for the TRE Certificate Holders of the Exchange.

According to information available from the Pakistan Stock Exchange (PSX), Highnoon Laboratories Limited is classified under the Pharmaceuticals segment, indicating its primary market focus. The leadership transition comes at a time when the company is navigating an evolving market landscape.

The change in chairmanship is significant for Highnoon Laboratories Limited as it strives to maintain its position and pursue growth in the pharmaceutical sector. The appointment of Mr. Tariq Wajid as Chairman is expected to bring a fresh perspective to the board, potentially impacting the company's strategic initiatives.